<DOC>
	<DOCNO>NCT00580385</DOCNO>
	<brief_summary>The purpose study investigate tumor laboratory determine respond , fail respond different drug therapy . This study also investigate high pressure develop within tumor affect well drug work . We also take blood sample and/or procedure measure biochemical factor may help u predict behavior osteogenic sarcoma solid tumor .</brief_summary>
	<brief_title>Chemotherapy Resistance Osteogenic Sarcoma Other Solid Tumors</brief_title>
	<detailed_description>When tumor tissue know presumed primary secondary bone cancer solid tumor know elevate intra-tumoral pressure retinoblastoma remove remove diagnostic therapeutic reason small sample obtain study . The tumor sample use study vitro , determinant chemotherapy resistance oncogenesis . These determinant correlate histologic response preoperative chemotherapy clinical outcome ( event free survival ) . In addition , blood sample ( 20ml ) may obtain procedure .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Osteosarcoma</mesh_term>
	<criteria>All patient presume known diagnosis primary secondary bone cancer solid tumor biopsy surgery remove tumor diagnostic therapeutic reason . No tumor obtain solely research purpose . All adult patient ( &gt; = 18 yr . ) give write informed consent . All minor patient ( &lt; 18 yr . ) give assent best ability understand , parent guardian give write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>BONE</keyword>
</DOC>